Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides

Experimental Biology and Medicine

Volumn 239, Issue 8, 2014, Pages 1025-1035

  Jia, Xuemei ^a,b   Iwanowycz, Stephen ^b   Wang, Junfeng ^b,c   Saaoud, Fatma ^b   Yu, Fang ^b,d   Wang, Yuzhen ^b   Hu, Jun ^e   Chatterjee, Saurabh ^e   Wang, Qian ^e   Fan, Daping ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

cytokine; Emodin; inflammation; macrophage; NAFLD

Indexed keywords

ALANINE AMINOTRANSFERASE; CHEMOKINE; CHOLESTEROL; CYTOKINE; EMODIN; GLUCOSE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; DRUG PURITY; FATTY LIVER; FEMALE; FLOW CYTOMETRY; FOOD INTAKE; HEPATITIS; HISTOLOGY; HYPERLIPIDEMIA; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; LIVER CELL; LIVER FUNCTION; MACROPHAGE CULTURE; MASS SPECTROMETRY; MOUSE; NICK END LABELING; NONALCOHOLIC FATTY LIVER; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN CELL; SYSTEMIC INFLAMMATION; TISSUE LEVEL; WESTERN BLOTTING;

EID: 84907075563     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214530247     Document Type: Article

References (35)

1. Hotamisligil GS.Inflammation and metabolic disorders.Nature. 2006;444:860-7
2. Farrell GC,Larter CZ.Nonalcoholic fatty liver disease: from steatosis to cirrhosis.Hepatology. 2006;43:S99-112
3. Farrell GC,van Rooyen D,Gan L,Chitturi S.NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications.Gut Liver. 2012;6:149-71
4. Williams CD,Stengel J,Asike MI,Torres DM,Shaw J,Contreras M,Landt CL,Harrison SA.Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.Gastroenterology. 2012;140:124-31
5. Neuschwander-Tetri BA.Nonalcoholic steatohepatitis and the metabolic syndrome.Am J Med Sci. 2005;330:326-35
6. Musso G,Gambino R,Cassader M.Non-alcoholic fatty liver disease from pathogenesis to management: an update.Obes Rev. 2009;11:430-45
7. Day CP,James OF.Steatohepatitis: a tale of two “hits”?.Gastroenterology. 1998;114:842-5
8. Cani PD,Possemiers S,Van de Wiele T,Guiot Y,Everard A,Rottier O,Geurts L,Naslain D,Neyrinck A,Lambert DM,Muccioli GG,Delzenne NM.Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.Gut. 2009;58:1091-103
9. Wigg AJ,Roberts-Thomson IC,Dymock RB,McCarthy PJ,Grose RH,Cummins AG.The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.Gut. 2001;48:206-11
10. Miele L,Valenza V,La Torre G,Montalto M,Cammarota G,Ricci R,Masciana R,Forgione A,Gabrieli ML,Perotti G,Vecchio FM,Rapaccini G,Gasbarrini G,Day CP,Grieco A.Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.Hepatology. 2009;49:1877-87
11. Brun P,Castagliuolo I,Di Leo V,Buda A,Pinzani M,Palu G,Martines D.Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.Am J Physiol Gastrointest Liver Physiol. 2007;292:G518-25
12. Park SH,Kim BI,Kim SH,Kim HJ,Park DI,Cho YK,Sung IK,Sohn CI,Kim H,Keum DK,Kim HD,Park JH,Kang JH,Jeon WK.Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men.J Am Coll Nutr. 2007;26:321-6
13. Park BJ,Kim YJ,Kim DH,Kim W,Jung YJ,Yoon JH,Kim CY,Cho YM,Kim SH,Lee KB,Jang JJ,Lee HS.Visceral adipose tissue area is an independent risk factor for hepatic steatosis.J Gastroenterol Hepatol. 2008;23:900-7
14. Fain JN,Madan AK,Hiler ML,Cheema P,Bahouth SW.Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans.Endocrinology. 2004;145:2273-82
15. Meng G,Liu Y,Lou C,Yang H.Emodin suppresses lipopolysaccharide-induced pro-inflammatory responses and NF-kappaB activation by disrupting lipid rafts in CD14-negative endothelial cells.Br J Pharmacol. 2010;161:1628-44
16. Li HL,Chen HL,Li H,Zhang KL,Chen XY,Wang XW,Kong QY,Liu J.Regulatory effects of emodin on NF-kappaB activation and inflammatory cytokine expression in RAW 264.7 macrophages.Int J Mol Med. 2005;16:41-7
17. Huang Z,Chen G,Shi P.Effects of emodin on the gene expression profiling of human breast carcinoma cells.Cancer Detect Prev. 2009;32:286-91
18. Dong H,Lu FE,Gao ZQ,Xu LJ,Wang KF,Zou X.Effects of emodin on treating murine nonalcoholic fatty liver induced by high caloric laboratory chaw.World J Gastroenterol. 2005;11:1339-44
19. Zhou M,Xu H,Pan L,Wen J,Guo Y,Chen K.Emodin promotes atherosclerotic plaque stability in fat-fed apolipoprotein E-deficient mice.Tohoku J Exp Med. 2008;215:61-9
20. Hei ZQ,Huang HQ,Tan HM,Liu PQ,Zhao LZ,Chen SR,Huang WG,Chen FY,Guo FF.Emodin inhibits dietary induced atherosclerosis by antioxidation and regulation of the sphingomyelin pathway in rabbits.Chin Med J (Engl). 2006;119:868-70
21. Alisi A,Pastore A,Ceccarelli S,Panera N,Gnani D,Bruscalupi G,Massimi M,Tozzi G,Piemonte F,Nobili V.Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats.Int J Mol Sci. 2012;13:2276-89
22. Larter CZ,Yeh MM.Animal models of NASH: getting both pathology and metabolic context right.J Gastroenterol Hepatol. 2008;23:1635-48
23. Larter CZ.Not all models of fatty liver are created equal: understanding mechanisms of steatosis development is important.J Gastroenterol Hepatol. 2007;22:1353-4
24. Tous M,Ferre N,Camps J,Riu F,Joven J.Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis.Mol Cell Biochem. 2005;268:53-8
25. Ishibashi S,Goldstein JL,Brown MS,Herz J,Burns DK.Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.J Clin Invest. 1994;93:1885-93
26. Knowles JW,Maeda N.Genetic modifiers of atherosclerosis in mice.Arterioscler Thromb Vasc Biol. 2000;20:2336-45
27. Cani PD,Bibiloni R,Knauf C,Waget A,Neyrinck AM,Delzenne NM,Burcelin R.Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.Diabetes. 2008;57:1470-81
28. Tilg H,Moschen AR.Inflammatory mechanisms in the regulation of insulin resistance.Mol Med. 2008;14:222-31
29. Cha TL,Qiu L,Chen CT,Wen Y,Hung MC.Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth.Cancer Res. 2005;65:2287-95
30. Feng Y,Huang SL,Dou W,Zhang S,Chen JH,Shen Y,Shen JH,Leng Y.Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice.Br J Pharmacol. 2010;161:113-26
31. Ma T,Qi QH,Xu J,Dong ZL,Yang WX.Signal pathways involved in emodin-induced contraction of smooth muscle cells from rat colon.World J Gastroenterol. 2004;10:1476-9
32. Xu JD,Liu S,Wang W,Li LS,Li XF,Li Y,Guo H,Ji T,Feng XY,Hou XL,Zhang Y,Zhu JX.Emodin induces chloride secretion in rat distal colon through activation of mast cells and enteric neurons.Br J Pharmacol. 2011;165:197-207
33. Bieghs V,Rensen PC,Hofker MH,Shiri-Sverdlov R.NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages.Atherosclerosis. 2012;220:287-93
34. Miyoshi T,Li Y,Shih DM,Wang X,Laubach VE,Matsumoto AH,Helm GA,Lusis AJ,Shi W.Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.Life Sci. 2006;79:525-31
35. Bhargava P,Lee CH.Role and function of macrophages in the metabolic syndrome.Biochem J. 2012;442:253-62